Englewood, CO
re-Contour is an early-stage startup that has identified a true clinical need associated with breast reconstruction post mastectomy, based on the personal breast cancer experience of its founder, Julie Hyde-Edwards. It has secured a patent for a medical device that addresses that need and will start marketing it to plastic surgeons and breast reconstruction patients upon completion ofโฆ ยท More commercialization activities. Julie has begun building a management team, consisting of Doug Rimatzki as chief executive and Dr. Kenneth Shaheen as chief medical officer.
recontour.ioThese are collections Recontour is a part of. Click on the collection name to view similar companies.
Seed
$3,700,000
Pre Seed
$200,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Recontour.